News - Page 10 of 11 - bm|t › next level funding

In the 2017 finan­cial year, over EUR 150 mil­lion flowed from pri­vate domes­tic and for­eign investors from the net­work of bm‑t beteili­gungs­man­age­ment thürin­gen gmbh (bm|t),

On 19 and 20 June 2018, entre­pre­neurs and investors will meet for the 15^th time at the Investor Days Thuringia at Messe Erfurt. Under the

It’s been just under a year since the founders of ifesca raised the seed round for their start-up. At that time, a high six-fig­ure sum

oncg­nos­tics GmbH has already reached the fund­ing limit of € 750,000 on the crowd­fund­ing plat­form seed­match 39 days before the end of the cam­paign. The first

Under the motto “Inno­v­a­tive? Excel­lent!”, the XX Inno­va­tion Award Thuringia 2017 was awarded on 21 Novem­ber 2017 by the Min­is­ter of Eco­nom­ics Wolf­gang Tiefensee together

The Ger­man start-up JeNa­Cell was voted “Sci­ence Start-up of the Year 2017” in Berlin. With its prod­uct, a wound dress­ing based on pure cel­lu­lose, large

Thuringia-based biotech com­pany inflaRx (NASDAQ: IFRX) suc­cess­fully com­pleted its ini­tial pub­lic offer­ing on the US tech­nol­ogy exchange Nas­daq yes­ter­day, rais­ing around $100 mil­lion. The company

The bm|t par­tic­i­pates in PAULfaehrtBus.de, a prod­uct of Mag­ni­tude Inter­net GmbH, via the Thuringian Start-up Fund (TSF). “We will tear down the exist­ing hur­dles in

AXSOL GmbH from Bleicherode/Obergebra has been named the state win­ner of Thuringia in the nation­wide busi­ness com­pe­ti­tion KfW Award Grün­den 2017. The award cer­e­mony will

Erfurt/Jena: Engin­sight GmbH, based in Jena, devel­ops and sells an inno­v­a­tive, autonomously act­ing mon­i­tor­ing plat­form that recog­nises depen­den­cies between IT resources and iden­ti­fies the critical

InflaRx, a biotech com­pany based in Jena, Ger­many, today pub­lished pos­i­tive data from its exploratory Phase IIa clin­i­cal trial with IFX‑1. The trial is for

Kevin Reeder (39) is the new Man­ag­ing Direc­tor of bm|t beteili­gungs­man­age­ment thürin­gen gmbh as of 1 Sep­tem­ber 2017. The US-born busi­ness econ­o­mist with an MBA

Erfurt/Jena: Red­wave Med­ical GmbH, based in Jena, Ger­many, devel­ops and dis­trib­utes a new type of algo­rithm for blood pres­sure mea­sur­ing devices for fast, inex­pen­sive and

bm‑t beteili­gungs­man­age­ment thürin­gen GmbH realises exit rubi­con IT GmbH acquires major­ity stake in PiNkey AG and plans to estab­lish a cen­tre of excel­lence for lost

The award cer­e­mony for the win­ners of a total of 149 appli­ca­tions took place in front of 300 guests from busi­ness, pol­i­tics and sci­ence at

Young entre­pre­neurs meet investors: Under the motto “Enter the next level”, this year’s Investor Days Thuringia kicked off today with 55 appli­cants and another 600

The Chi­nese phar­ma­ceu­ti­cal com­pany Changchun Jienuo Med­ical Tech­nol­ogy (CJMT), a sub­sidiary of the Chi­nese state-owned Sinopharm Group (www.sinopharm.com/en), has acquired an exclu­sive licence for the

The biotech com­pany oncg­nos­tics GmbH (www.oncgnostics.com), provider of the cer­vi­cal can­cer test “Gyn­Tect”, ends its crowd­in­vest­ing cam­paign on Seed­match very suc­cess­fully. Even before the end